Amarin Corp Plc\uk SEC filings AMRN
Amarin Corp Plc\uk has 1,003 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 31, 2025 | — |
| PRER14A | Filing | Apr 7, 2025 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2023 | — |
| EFFECT | Filing | Aug 15, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2023 | — |
| DFAN14A | Filing | Feb 28, 2023 | — |
| DFAN14A | Filing | Feb 27, 2023 | — |
| DFAN14A | Filing | Feb 21, 2023 | — |
| DFAN14A | Filing | Feb 21, 2023 | — |
| DFAN14A | Form dfan14a | Feb 17, 2023 | — |
| DFAN14A | Filing | Feb 16, 2023 | — |
| DFAN14A | Filing | Feb 15, 2023 | — |
| DFAN14A | Filing | Feb 14, 2023 | — |
| DFAN14A | Filing | Feb 13, 2023 | — |
| CT ORDER | Filing | Feb 13, 2023 | — |
| DFAN14A | Filing | Feb 9, 2023 | — |
| DFAN14A | Filing | Feb 8, 2023 | — |
| DFAN14A | Filing | Feb 7, 2023 | — |
| DFAN14A | Filing | Feb 3, 2023 | — |
| DFAN14A | Filing | Feb 2, 2023 | — |
| DFAN14A | Filing | Feb 1, 2023 | — |
| DEFC14A | Filing | Jan 31, 2023 | — |
| PRRN14A | Filing | Jan 31, 2023 | — |
| DEFC14A | Filing | Jan 31, 2023 | — |
| PRRN14A | Filing | Jan 31, 2023 | — |
| PRRN14A | Filing | Jan 27, 2023 | — |
| PRER14A | Filing | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| PRER14A | Filing | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2023 | — |
| PREC14A | Filing | Jan 18, 2023 | — |
| DFAN14A | Filing | Jan 18, 2023 | — |
| PREC14A | Filing | Jan 17, 2023 | — |
| DFAN14A | Filing | Jan 10, 2023 | — |
| DFAN14A | Filing | Oct 11, 2022 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| CT ORDER | Filing | Sep 22, 2017 | — |
| SC TO-I/A | Filing | Jan 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2017 | — |
| CORRESP | Letter to the SEC | Jan 9, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2016 | — |
| SC TO-I | Filing | Dec 16, 2016 | — |
| EFFECT | Filing | Aug 7, 2015 | — |
| CORRESP | Letter to the SEC | Aug 5, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2015 | — |
| CT ORDER | Filing | Jul 1, 2015 | — |
| EFFECT | Filing | May 1, 2015 | — |
| EFFECT | Filing | May 1, 2015 | — |
| CORRESP | Letter to the SEC | Apr 29, 2015 | — |
| CORRESP | Letter to the SEC | Apr 24, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2015 | — |
| EFFECT | Filing | Aug 22, 2014 | — |
| DEL AM | Del-am | Aug 15, 2014 | — |
| CT ORDER | Filing | Jun 26, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2013 | — |
| CORRESP | Letter to the SEC | Oct 4, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2013 | — |
| CT ORDER | Filing | Apr 17, 2013 | — |
| CT ORDER | Filing | Nov 23, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2012 | — |
| CORRESP | Letter to the SEC | Oct 3, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2012 | — |
| CT ORDER | Filing | Sep 14, 2012 | — |
| CT ORDER | Filing | Aug 6, 2012 | — |
| CT ORDER | Filing | Mar 19, 2012 | — |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Dublin 2
- SEC filer status
- Accelerated filer
- SEC CIK
- 897448
- Former names
- AMARIN CORP PLC\UK (until Oct 28, 2026); AMARIN PHARMACEUTICALS PLC (until Jul 13, 2000); ETHICAL HOLDINGS PLC (until Jan 28, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.